Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Other
  • 225: An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator
  • Other

225: An Interview With Craig Martin, Founder and CEO of the Orphan Therapeutics Accelerator

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Craig Martin, founder and CEO of the Orphan Therapeutics Accelerator (OTXL) -- a nonprofit biotech dedicated to advancing shelved

Rare Disease

Read full story

pharminent May 18, 2026 (Last updated: May 21, 2026)

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Craig Martin, founder and CEO of the Orphan Therapeutics Accelerator (OTXL) — a nonprofit biotech dedicated to advancing shelved

Rare Disease

Read full story

Post navigation

Previous: Merck ADC, licensed from China, hits mark in first big global trial
Next: SCOTUS won’t hear pharma’s IRA complaints

Related Stories

  • Other

Takeda and Weave Bio collaborate on AI-driven automation in drug development

pharminent September 2, 2026
  • Other

ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

pharminent June 2, 2026
  • Other

ASCO26: Symptom-tracking app helps advanced cancer patients

pharminent June 2, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.